Related Experiment Video

Updated: Jun 12, 2026

Exploring the Pharmacological Action and Molecular Mechanism of Salidroside in Inhibiting MCF-7 Cell Proliferation and Migration
11:13

Exploring the Pharmacological Action and Molecular Mechanism of Salidroside in Inhibiting MCF-7 Cell Proliferation and Migration

Published on: June 9, 2023

PTPL1/PTPN13 regulates breast cancer cell aggressiveness through direct inactivation of Src kinase

Murielle Glondu-Lassis1, Mathilde Dromard, Magali Lacroix-Triki

  • 1IRCM, Institut de Recherche en Cancérologie de Montpellier, Montpellier, France.

Cancer Research
|May 27, 2010
PubMed

Insights

The protein tyrosine phosphatase PTPL1/PTPN13 acts as a tumor suppressor by inhibiting breast cancer progression. Its reduced expression increases tumor growth and metastasis by activating Src kinase.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • The protein tyrosine phosphatase PTPL1/PTPN13 is implicated as a tumor suppressor gene due to decreased activity in some cancers.
  • Clinical studies show PTPL1 expression is a favorable prognostic indicator in breast cancer patients.
  • The precise mechanisms by which PTPL1 influences breast tumor aggressiveness remain uncharacterized.

Purpose of the Study:

  • To investigate the role of PTPL1 in breast cancer progression and metastasis.
  • To elucidate the molecular mechanisms underlying PTPL1's tumor-suppressive function.
  • To identify PTPL1 as a potential therapeutic target for breast cancer treatment.

Main Methods:

  • Immunohistochemistry to assess PTPL1 expression in breast cancer tissues.
  • RNA interference to inhibit PTPL1 in MCF-7 breast cancer cells.
  • In vivo tumor growth studies in athymic mice.
  • Analysis of Src kinase activation and downstream signaling pathways (Fak, p130cas).
  • Substrate-trapping experiments to identify direct phosphatase targets.

Main Results:

  • PTPL1 expression is significantly decreased in breast cancer and metastatic tissues compared to nonmalignant tissues.
  • PTPL1 inhibition in MCF-7 cells led to increased tumor growth, proliferation, and invasion in vivo.
  • Silencing PTPL1 increased Src kinase phosphorylation at tyrosine 419, activating downstream effectors Fak and p130cas.
  • Src tyrosine 419 was identified as a direct dephosphorylation target of PTPL1.

Conclusions:

  • PTPL1 acts as a direct inhibitor of Src kinase activity through dephosphorylation, representing a novel tumor suppressive mechanism.
  • Reduced PTPL1 expression contributes to breast cancer progression and aggressiveness by promoting Src-mediated signaling.
  • PTPL1 is a critical regulator of breast tumor aggressiveness and a potential therapeutic target.

More Related Videos

Assessing Cellular Target Engagement by SHP2 (PTPN11) Phosphatase Inhibitors08:45

Assessing Cellular Target Engagement by SHP2 (PTPN11) Phosphatase Inhibitors

Published on: July 17, 2020

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...